Mechanistically, SIGIRR suppressed the sustained activation of AKT, whereas IL-37 deprived DC cells of their resistance to tumour occurrence by regulating the SIGIRR-AMPK-Akt signalling axis, which is strongly associated with CD103-positive DCs. The gene discussed is AKT1; the disease is neoplasm.